These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 34162560

  • 1. miRNA-93-5p Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Targeting the PTEN-Mediated PI3K/Akt Signaling Pathway.
    Wu Y, Xu W, Yang Y, Zhang Z.
    Ann Clin Lab Sci; 2021 May; 51(3):310-320. PubMed ID: 34162560
    [Abstract] [Full Text] [Related]

  • 2. circACTR2 attenuates gemcitabine chemoresiatance in pancreatic cancer through PTEN mediated PI3K/AKT signaling pathway.
    Xu C, Ye Q, Ye C, Liu S.
    Biol Direct; 2023 Mar 30; 18(1):14. PubMed ID: 36991449
    [Abstract] [Full Text] [Related]

  • 3. Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer.
    Gu J, Huang W, Wang X, Zhang J, Tao T, Zheng Y, Liu S, Yang J, Chen ZS, Cai CY, Li J, Wang H, Fan Y.
    Mol Cancer; 2022 May 10; 21(1):112. PubMed ID: 35538494
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway.
    Sun ZY, Jian YK, Zhu HY, Li B.
    Pathol Res Pract; 2019 Mar 10; 215(3):555-563. PubMed ID: 30661902
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT.
    Tan J, You Y, Xu T, Yu P, Wu D, Deng H, Zhang Y, Bie P.
    Toxicol Lett; 2014 Jan 03; 224(1):7-15. PubMed ID: 24144893
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes.
    Zhou C, Yi C, Yi Y, Qin W, Yan Y, Dong X, Zhang X, Huang Y, Zhang R, Wei J, Ali DW, Michalak M, Chen XZ, Tang J.
    Mol Cancer; 2020 Jul 29; 19(1):118. PubMed ID: 32727463
    [Abstract] [Full Text] [Related]

  • 15. MiR-202-5p/PTEN mediates doxorubicin-resistance of breast cancer cells via PI3K/Akt signaling pathway.
    Liu T, Guo J, Zhang X.
    Cancer Biol Ther; 2019 Jul 29; 20(7):989-998. PubMed ID: 30983514
    [Abstract] [Full Text] [Related]

  • 16. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhang P, Lu X, Shi Z, Li X, Zhang Y, Zhao S, Liu H.
    Gene; 2019 Aug 20; 710():103-113. PubMed ID: 31158447
    [Abstract] [Full Text] [Related]

  • 17. miR-129-5p inhibits gemcitabine resistance and promotes cell apoptosis of bladder cancer cells by targeting Wnt5a.
    Cao J, Wang Q, Wu G, Li S, Wang Q.
    Int Urol Nephrol; 2018 Oct 20; 50(10):1811-1819. PubMed ID: 30117016
    [Abstract] [Full Text] [Related]

  • 18. MiR-17-5p inhibits cerebral hypoxia/reoxygenationinjury by targeting PTEN through regulation of PI3K/AKT/mTOR signaling pathway.
    Ren X, Jing YX, Zhou ZW, Yang QM.
    Int J Neurosci; 2022 Feb 20; 132(2):192-200. PubMed ID: 32762281
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X, Wen H, Jing L, Yang Y, Wang W, Liang X, Nan K, Yao Y, Tian T.
    Cancer Sci; 2017 Apr 20; 108(4):620-631. PubMed ID: 28132399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.